No association was found between any IAPP SNP and altered phenotypes of BMD, QUS or body composition.
Results
No association was found between any IAPP SNP and altered phenotypes of BMD, QUS or body composition.
For IAPP rs5484, heterozygous (CT) individuals and those homozygous for the major allele (CC) had a 1.8 and 1.7 times risk respectively of osteoporotic fracture compared to those homozygous for the minor allele (TT), however neither were significant (p=.058 and p=.080).
An increased risk of fracture was also apparent when measured over a 15 year follow-up in those heterozygous (CT) subjects (HR 1.6 (CI: 0.962-2.67), P = 0.07) and homozygous for the major allele (CC) (HR 1.52 (CI: 0.919-2.52), P = 0.10) compared to those homozygous for the minor allele.
Introduction
Osteoporosis is a systemic skeletal disease characterized by reduced bone mineral density (BMD), leading to enhanced bone fragility, and a consequent increase in fracture risk (1) . Amylin, also known as Islet Amyloid Polypeptide (IAPP), is co-secreted with insulin from pancreatic B-cells; stimulates bone formation and decreases bone resorption via its action on osteoblasts and osteoclasts (2, 3) and also has the ability to reduce body weight (4, 5) . Osteoporosis is a complex, polygenic disorder (6) and the potential for amylin as a candidate gene is highlighted by the large number of diabetics who suffer from osteopenia (7) .
Conclusion
The present prospective data suggest no association between the IAPP variants tested and altered BMD in elderly women.
However replication studies are required to fully explore the association of IAPP rs5484 and risk of osteoporotic fracture in additional cohorts.
Patients and Methods
We investigated the association between 4 single nucleotide polymorphisms (SNPs) in the IAPP gene and BMD, quantitative ultrasound (QUS) and fracture risk -taking into account body composition-in 75 year old women prospectively followed for up to 15 years (OPRA cohort; n=1003) (8) . The association between IAPP genotype and BMD and QUS was analysed using a general liner model analysis of variance (GLM-ANOVA). The association between genotype and incident fractures was estimated using binary logistic regression and the association between genotype and incident fractures over 15 years of follow up was determined using a Cox's regression model. All analyses were adjusted for the covariates weight and current smoking status. The OPRA study had >80% power to detect relative risks for fracture of at least 1. 
